ArticleScientific reports2024
Robust diabetic prediction using ensemble machine learning models with synthetic minority over-sampling technique.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- CSF1R and macrophage infiltration: Integrated magnetic resonance imaging radiomics and deep learning-driven models for the preoperative assessment of glioma.Chinese medical journal · 2026Article
- Stacked ensemble learning and in-silico profiling reveal dual DPP-IV and SGLT2 inhibitors from Moringa oleifera metabolites.Scientific reports · 2026Article
- Development and internal validation of a post-retrieval machine learning models for OHSS risk stratification in assisted reproductive technology: an exploratory study.Frontiers in endocrinology · 2026Article
- Seamless integration for enhanced seizure prediction using HybridConvMobileNet on Typhoon HIL.Scientific reports · 2025Article
- Machine Learning-Driven Insights in Cancer Metabolomics: From Subtyping to Biomarker Discovery and Prognostic Modeling.Metabolites · 2025Review
- Study on a Traditional Chinese Medicine constitution recognition model using tongue image characteristics and deep learning: a prospective dual-center investigation.Chinese medicine · 2025Article
- Leveraging advanced graph neural networks for the enhanced classification of post anesthesia states to aid surgical procedures.PloS one · 2025Article
- Real-world data-driven early warning system for risk-stratified liver injury in hospitalized COVID-19 patients-Machine learning models for clinical decision support.Frontiers in public health · 2025Article
- Enhancing diabetes risk prediction through focal active learning and machine learning models.PloS one · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper addresses the pressing issue of diabetes, which is a widespread condition affecting a huge population worldwide. As cells become less responsive to insulin or fail to produce it adequately, blood sugar levels rise. This has the potential to cause severe health complications including kidney disease, vision impairment and heart conditions. Early diagnosis is paramount in mitigating the risk and severity of diabetes-related complications. To tackle this, we proposed a robust framework for diabetes prediction using Synthetic Minority Over-sampling Technique (SMOTE) with ensemble machine learning techniques. Our approach incorporates strategies such as imputation of missing values, outlier rejection, feature selection using correlation analysis and class distribution balancing using SMOTE. The extensive experimentation shows that the proposed combination of AdaBoost and XGBoost shows exceptional performance, with an impressive AUC of 0.968+/-0.015. This outperforms not only alternative methodologies presented in our study but also surpasses current state-of-the-art results. We anticipate that our model will significantly improve diabetes prediction, offering a promising avenue for improved healthcare outcomes in diabetes management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.